Lexanopadol, formerly known as GRT6006, is a potent ORL-1 agonist (opioid receptor like -1). Preliminary evidence suggests that targeting ORL-1 receptors may have synergistic effects with mu receptors hence enhancing the therapeutic profile of Lexanopadol in the treatment of pain. Lexanopadol is particularly suited for the management of moderate to severe chronic pain, including neuropathic pain. References:

纯度：≥98%

CAS：1357348-09-4